Chinook Therapeutics, a Novartis Company Email Format
Biotechnology ResearchWashington, United States201-500 Employees
Chinook Therapeutics is now a Novartis Company! On August 11, 2023, Novartis completed its acquisition of Chinook. Follow the Novartis channel or visit www.novartis.com to stay updated on atrasentan, zigakibart and the rest of the Chinook pipeline. For more information on the acquisition, see our press release at: https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics See our community guidelines: https://go.novartis.social/3Slt0Up